Zimmer Biomet (ZBH) News Today

Jacobs & Co. CA reduced its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 32.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,767 shares of the medical equipment provider's s

Brown Financial Advisors bought a new stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 8,205 shares of the medical equipment provider's stock, valu

Evercore ISI lowered their price target on shares of Zimmer Biomet from $113.00 to $110.00 and set an "in-line" rating for the company in a report on Tuesday.

The Manufacturers Life Insurance Company cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 2.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 312,534 shares of the medical equipment provider's stock after selling 6,90

MBB Public Markets I LLC raised its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 440.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,095 shares of the medical equipment provider's s

APG Asset Management N.V. raised its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 12.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 176,729 shares of the medical equipment

D. E. Shaw & Co. Inc. boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 329.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 490,138 shares of the medical equipment provider's

Axa S.A. boosted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 263.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 253,958 shares of the medical equipment provider's stock after acquiring an additional

Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Get Free Report) has received an average rating of "Hold" from the twenty ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and six h

Ariel Investments LLC boosted its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 297,401 shares of the medical equipment

Point72 Europe London LLP bought a new stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 68,202 shares of the medical equipment pr

Shapiro Capital Management LLC lifted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 11.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,028,361 shares of the medical equipment provider's stock a

Magnetar Financial LLC increased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 58.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,310,265 shares of the medical equipment provider'

Thrivent Financial for Lutherans lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 3.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 911,644 shares of the me

Renaissance Technologies LLC purchased a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 180,900 shares of the medical equipment provider's s

Simplify Asset Management Inc. decreased its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 92.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,038 shares of the medical

MQS Management LLC bought a new stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 8,302 shares of the medical equipment provider's stock,

Seven Eight Capital LP boosted its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 1,551.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,978 shares of the medical equipment provider's stock after purchasing an additional 34

Needham & Company LLC reaffirmed a "hold" rating on shares of Zimmer Biomet in a report on Tuesday.

Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.

Sofinnova Investments Inc. purchased a new position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,630 shares of the medical equipment provider's sto

JPMorgan Chase & Co. reduced their price objective on Zimmer Biomet from $125.00 to $120.00 and set a "neutral" rating for the company in a research report on Monday.

State of New Jersey Common Pension Fund D cut its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 40.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 67,178 shares of the medical equipmen

Texas Permanent School Fund Corp lessened its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 22.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 33,609 shares of the medical equipment prov

Forsta AP Fonden lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 14.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 85,100 shares of the medical equipment

Truist Financial restated a "hold" rating and set a $112.00 price target (down from $117.00) on shares of Zimmer Biomet in a research report on Friday.

American Century Companies Inc. lifted its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 12.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,463,845 shares of the medical equipment provid

Headlands Technologies LLC lifted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 895.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,131 shares of the medical equipment

Canaccord Genuity Group decreased their price target on shares of Zimmer Biomet from $120.00 to $115.00 and set a "hold" rating for the company in a research report on Tuesday.

Eubel Brady & Suttman Asset Management Inc. lifted its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 2.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 229,375 shares

Quest Partners LLC increased its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH - Free Report) by 183,680.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,378 shares of the medical eq